Cite
The Utility of Inflammatory Biomarkers in Predicting Overall Survival and Recurrence among Primary Skull Base Chordoma Patients.
MLA
Muthiah, Nallammai, et al. “The Utility of Inflammatory Biomarkers in Predicting Overall Survival and Recurrence among Primary Skull Base Chordoma Patients.” Journal of Neurological Surgery. Part B. Skull Base, vol. 84, Feb. 2023, pp. S1–344. EBSCOhost, https://doi.org/10.1055/s-0043-1762176.
APA
Muthiah, N., Gersey, Z., Hoppe, M., Abdallah, H., Wang, E., Synderman, C., Zenonos, G., & Gardner, P. (2023). The Utility of Inflammatory Biomarkers in Predicting Overall Survival and Recurrence among Primary Skull Base Chordoma Patients. Journal of Neurological Surgery. Part B. Skull Base, 84, S1–S344. https://doi.org/10.1055/s-0043-1762176
Chicago
Muthiah, Nallammai, Zachary Gersey, Meagan Hoppe, Hussein Abdallah, Eric Wang, Carl Synderman, Georgios Zenonos, and Paul Gardner. 2023. “The Utility of Inflammatory Biomarkers in Predicting Overall Survival and Recurrence among Primary Skull Base Chordoma Patients.” Journal of Neurological Surgery. Part B. Skull Base 84 (February): S1–344. doi:10.1055/s-0043-1762176.